{"id":"W2978854127","doi":"10.1093/annonc/mdz394.008","title":"Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer","year":2019,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Veliparib; Medicine; Carboplatin; Paclitaxel; Oncology; Metastatic breast cancer; PARP inhibitor; Internal medicine; Breast cancer; Cancer; Chemotherapy; Cisplatin; Poly ADP ribose polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688996,0.001380386,0.002866889,0.0006222649,0.0006698042,0.001844107,0.001765113,0.001527515,0.003620619],"category_scores_gemma":[0.0008260884,0.0007896334,0.001612541,0.0007361956,0.001393887,0.00109748,0.0004896601,0.005141623,0.001253839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001555253,"about_ca_system_score_gemma":0.002560477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003222359,"about_ca_topic_score_gemma":0.005775234,"domain_scores_codex":[0.9995064,0.0002143708,0.00002044514,0.00008633983,0.00003606295,0.0001363219],"domain_scores_gemma":[0.9992666,0.0001067375,0.00009499215,0.00007917311,0.00003647804,0.0004161339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7287486,0.1181089,0.00368551,0.0007119046,0.002163536,0.0003071969,0.0004057063,0.006370673,0.03594006,0.0006277901,0.005235962,0.09769425],"study_design_scores_gemma":[0.6339006,0.3484371,0.006499047,0.00004469764,0.0006098493,0.0003061435,0.00012811,0.002449688,0.003881573,0.0004112432,0.003296006,0.00003608083],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900402,0.002472743,0.0007468612,0.000606484,0.0002125363,0.002300012,0.001102483,0.0001640707,0.002354711],"genre_scores_gemma":[0.9869898,0.002512108,0.0018662,0.0008158094,0.0001671987,0.002393774,0.002128772,0.00008545577,0.003040892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003620619,"threshold_uncertainty_score":0.0121122,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09477682576886066,"score_gpt":0.4793402547310751,"score_spread":0.3845634289622144,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}